{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T10:13:57Z","timestamp":1789899237916,"version":"4.0.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.annder.2011.01.004","type":"journal-article","created":{"date-parts":[[2011,2,17]],"date-time":"2011-02-17T06:35:50Z","timestamp":1297924550000},"page":"173-181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Pemphigo\u00efde bulleuse\u00a0: revue de la litt\u00e9rature"],"prefix":"10.1016","volume":"138","author":[{"given":"P.","family":"Bernard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Charneux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.annder.2011.01.004_bib0005","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/archderm.1995.01690130050009","article-title":"Incidence and distribution of subepidermal auto-immune bullous skin diseases in three French regions","volume":"131","author":"Bernard","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2011.01.004_bib0010","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.yadr.2007.07.013","article-title":"Bullous pemphigoid: physiopathology, clinical features and management","volume":"23","author":"Di Zenzo","year":"2007","journal-title":"Adv Dermatol"},{"key":"10.1016\/j.annder.2011.01.004_bib0015","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1046\/j.1365-2133.1997.6581643.x","article-title":"Anti-BP180\u00a0autoantibodies as a marker of poor vital prognosis in bullous pemphigoid: a cohort analysis of 94\u00a0elderly patients","volume":"136","author":"Bernard","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2011.01.004_bib0020","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1001\/archderm.134.4.465","article-title":"High risk of death in elderly patients with extensive bullous pemphigoid","volume":"134","author":"Roujeau","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2011.01.004_bib0025","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1001\/archderm.141.6.691","article-title":"Prediction of survival for patients with bullous pemphigoid: a prospective study","volume":"141","author":"Joly","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2011.01.004_bib0030","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000075040","article-title":"Clinical criteria for the diagnosis of bullous pemphigoid: a reevaluation according to immunoblot analysis of patient sera","volume":"208","author":"Joly","year":"2004","journal-title":"Dermatology"},{"key":"10.1016\/j.annder.2011.01.004_bib0035","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1001\/archderm.136.2.174","article-title":"Serum levels of autoantibodies to BP180\u00a0correlate with disease activity in patients with bullous pemphigoid","volume":"136","author":"Schmidt","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2011.01.004_bib0040","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jdermsci.2005.11.002","article-title":"Enzyme-linked immunosorbent assay using bacterial recombinant proteins of human BP230\u00a0as a diagnostic tool for bullous pemphigoid","volume":"41","author":"Yoshida","year":"2006","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.annder.2011.01.004_bib0045","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1001\/archderm.134.9.1075","article-title":"Evaluation of clinical criteria for diagnosis of bullous pemphigoid","volume":"134","author":"Vaillant","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2011.01.004_bib0050","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1056\/NEJM199511303332207","article-title":"Management of auto-immune bullous disases","volume":"333","author":"Fine","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annder.2011.01.004_bib0055","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1001\/archderm.138.7.903","article-title":"Risk factors for lethal outcome in patients with bullous pemphigoid","volume":"138","author":"Rzany","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2011.01.004_bib0060","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1046\/j.1365-2133.2002.04835.x","article-title":"Guidelines for the management of bullous pemphigoid","volume":"147","author":"Wojnarowska","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2011.01.004_bib0065","first-page":"CD002292","article-title":"Interventions for bullous pemphigoid","volume":"3","author":"Khumalo","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.annder.2011.01.004_bib0070","first-page":"925","article-title":"Traitement de la pemphigo\u00efde bulleuse par la prednisolone seule\u00a0: 0,75\u00a0mg\/kg par jour contre 1,25\u00a0mg\/kg par jour. \u00c9tude randomis\u00e9e multicentrique","volume":"111","author":"Morel","year":"1984","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.annder.2011.01.004_bib0075","first-page":"518","article-title":"Methylprednisolone versus prednisolone methylsulfobenzoate in pemphigoid: a comparative multicenter study","volume":"120","author":"Dreno","year":"1993","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.annder.2011.01.004_bib0080","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/archderm.1993.01680220061016","article-title":"Controlled trial of azathioprine and plasma exchange in addition to prednisolone in the treatment of bullous pemphigoid","volume":"129","author":"Guillaume","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2011.01.004_bib0085","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S0140-6736(84)92565-0","article-title":"Plasma exchange in bullous pemphigoid","volume":"2","author":"Roujeau","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.annder.2011.01.004_bib0090","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJMoa011592","article-title":"A comparison of oral and topical corticosteroids in patients with bullous pemphigoid","volume":"346","author":"Joly","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annder.2011.01.004_bib0095","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1001\/archderm.1984.01650450039014","article-title":"High-dose methylprednisolone in the treatment of bullous pemphigoid","volume":"120","author":"Siegel","year":"1984","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2011.01.004_bib0100","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1001\/archdermatol.2009.53","article-title":"Risk factors for relapse in patients with bullous pemphigoid in clinical remission: a multicentre, prospective, cohort study","volume":"145","author":"Bernard","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2011.01.004_bib0105","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0190-9622(89)70058-X","article-title":"Treatment of bullous pemphigoid with topical clobetasol propionate","volume":"20","author":"Westerhof","year":"1989","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2011.01.004_bib0110","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1038\/jid.2008.412","article-title":"A comparison of two regimens of topical corticosteroids in the treatment of patients with bullous pemphigoid: a multicenter randomized study","volume":"129","author":"Joly","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.annder.2011.01.004_bib0115","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1136\/bmj.2.6146.1190","article-title":"Azathioprine plus prednisone in treatment of pemphigoid","volume":"2","author":"Burton","year":"1978","journal-title":"Br Med J"},{"key":"10.1016\/j.annder.2011.01.004_bib0120","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0140-6736(97)80092-X","article-title":"Bullous pemphigoid treated with mycophenolate mofetil","volume":"349","author":"Bohm","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.annder.2011.01.004_bib0125","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0190-9622(99)70084-8","article-title":"Mycophenolate mofetil: a new therapeutic option in the treatment of blistering auto-immune diseases","volume":"40","author":"Grundmann-Kollmann","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2011.01.004_bib0130","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1001\/archderm.143.12.1536","article-title":"A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoid","volume":"143","author":"Beissert","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2011.01.004_bib0135","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0190-9622(99)70156-8","article-title":"Low-dose oral pulse methotrexate as monotherapy in elderly patients with bullous pemphigoid","volume":"40","author":"Heilborn","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2011.01.004_bib0140","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1001\/archderm.144.5.612","article-title":"A retrospective analysis of patients with bullous pemphigoid treated with methotrexate","volume":"144","author":"Kjellman","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2011.01.004_bib0145","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1001\/archderm.138.9.1255","article-title":"Treatment of bullous pemphigoid by low-dose methotrexate associated with short-term potent topical steroids: an open prospective study of 18\u00a0cases","volume":"138","author":"Dereure","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2011.01.004_bib0150","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1001\/archderm.139.11.1506-b","article-title":"Methotrexate for bullous pemphigoid: preliminary study","volume":"139","author":"Bara","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2011.01.004_bib0155","first-page":"1223","article-title":"L\u2019association corticost\u00e9ro\u00efdes-cyclophosphamide d\u2019embl\u00e9e dans le traitement de la pemphigo\u00efde bulleuse","volume":"113","author":"Taieb","year":"1986","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.annder.2011.01.004_bib0160","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/0190-9622(90)70111-T","article-title":"The use of chlorambucil in the treatment of bullous pemphigoid","volume":"22","author":"Milligan","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2011.01.004_bib0165","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/j.1365-2133.2003.05611.x","article-title":"Topical tacrolimus therapy for localized bullous pemphigoid","volume":"149","author":"Ko","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2011.01.004_bib0170","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/archderm.139.6.813","article-title":"Topical tacrolimus is a useful adjunctive therapy for bullous pemphigoid","volume":"139","author":"Chu","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2011.01.004_bib0175","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1001\/archderm.136.10.1204","article-title":"Bullous pemphigoid treated with leflunomide","volume":"136","author":"Nousari","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2011.01.004_bib0180","unstructured":"Depaire-Duclos F, Dandurand M, Basset-Seguin N, Guilhou JJ, Guillot B. Treatment of bullous pemphigoid with tetracyclines and topical corticosteroids. Eur J Dermatol 1997;7:570\u20133."},{"key":"10.1016\/j.annder.2011.01.004_bib0185","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1001\/archderm.1986.01660180076019","article-title":"The treatment of bullous pemphigoid with tetracycline and nicotinamide","volume":"122","author":"Berk","year":"1986","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2011.01.004_bib0190","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1001\/archderm.1994.01690060083010","article-title":"Nicotinamide and tetracycline therapy of bullous pemphigoid","volume":"130","author":"Fivenson","year":"1994","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2011.01.004_bib0195","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0190-9622(96)80085-5","article-title":"Treatment of bullous pemphigoid with dapsone: retrospective study of 36\u00a0cases","volume":"34","author":"Bouscarat","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2011.01.004_bib0200","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2340\/00015555667375","article-title":"Long term plasma exchange therapy in bullous pemphigoid","volume":"66","author":"Guillot","year":"1986","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.annder.2011.01.004_bib0205","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1046\/j.1365-2133.1999.02817.x","article-title":"High-dose intravenous immune globulin for the treatment of auto-immune blistering diseases: an evaluation of its use in 14\u00a0cases","volume":"140","author":"Harman","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2011.01.004_bib0210","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1067\/mjd.2001.116337","article-title":"Intravenous immunoglobulin therapy for patients with bullous pemphigoid unresponsive to conventional immunosuppressive treatment","volume":"45","author":"Ahmed","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2011.01.004_bib0215","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/sj.bmt.1703654","article-title":"Combination treatment of bullous pemphigoid with anti-CD20\u00a0and anti-CD25\u00a0antibodies in a patient with chronic graft-versus-host disease","volume":"30","author":"Szabolcs","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.annder.2011.01.004_bib0220","doi-asserted-by":"crossref","unstructured":"Reguiai Z, Tchen T, Perceau G, Bernard P. Efficacit\u00e9 du rituximab dans une pemphigo\u00efde bulleuse en \u00e9chec th\u00e9rapeutique. Ann Dermatol V\u00e9n\u00e9r\u00e9ol 2009;136:431\u20134.","DOI":"10.1016\/j.annder.2008.10.038"}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963811000093?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963811000093?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T10:58:08Z","timestamp":1758970688000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0151963811000093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0151963811000093"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2011.01.004","relation":{},"ISSN":["0151-9638"],"issn-type":[{"value":"0151-9638","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pemphigo\u00efde bulleuse\u00a0: revue de la litt\u00e9rature","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2011.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}